Sky Medical Technology, a United Kingdom-based medical devices company and manufacturer of the geko device, has received the Innovation Award at the Medilink North of England Healthcare Business Awards 2020, it was reported on Wednesday.

The award honours the company's collaboration with the NHS Royal Stoke University Hospital in generating compelling real-world data that has reported a zero VTE incidence (venous thromboembolism) in immobile acute stroke patients prescribed the geko device alone. The data has changed clinical practice at the Royal Stoke, driven wider NHS adoption across multiple acute Stroke units and critically, helped Sky achieve FDA 510(k) clearance in the US, making geko the first device of its kind to be approved by the FDA for VTE prevention across all patients, including non-surgical patients - and a first new approach in 20 years.

Sky CCO Andrew Thelwell said, 'I would like to thank Medilink for recognising excellence in technology deployment achieved through outstanding industry and NHS partnering. Partnership makes us who we are and we are enormously proud to bring to market an innovative therapy that completely redefines the way VTE prevention and vascular related conditions can now be treated and to have achieved this in partnership with the Royal Stoke Hospital acute Stroke team.'